In the US, CYMBALTA (duloxetine systemic) is a member of the drug class serotonin-norepinephrine reuptake inhibitors and is used to treat Anxiety, Back Pain, Chronic Pain, Depression, Diabetic Peripheral Neuropathy, Fibromyalgia, Generalized Anxiety Disorder, Major Depressive Disorder and Osteoarthritis.
Ingredient matches for CYMBALTA
Duloxetine is reported as an ingredient of CYMBALTA in the following countries:
- Bosnia & Herzegowina
Duloxetine hydrochloride (a derivative of Duloxetine) is reported as an ingredient of CYMBALTA in the following countries:
- Croatia (Hrvatska)
- Czech Republic
- Hong Kong
- Russian Federation
- South Africa
- South Korea
- United Kingdom
- United States
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.